KPV Tripeptide 5mg
Size: 5mg | 99% Purity
M.Wt: 329.43
Formula: Lys-Pro-Val
Solubility: H2O
Purity: >99%
Storage: -20°C / 3 years
Half life: Not established
CAS No.: 159492-07-6
| Purity (HPLC) | >99% |
|---|---|
| Molecular weight | 329.43 g/mol |
| Molecular formula | Lys-Pro-Val |
| CAS number | 159492-07-6 |
| Synonyms | KPV, Lys-Pro-Val, alpha-MSH C-terminal tripeptide |
| Solubility | H2O |
| Storage | -20°C / 3 years |
Peptide sequence
Lys-Pro-ValHPLC and MS verified by UKAS-accredited laboratories.
Royal Mail 24 and DPD Next Day options.
COA and batch number on every vial.
Description
Size: 5mg | 99% Purity
M.Wt: 329.43
Formula: Lys-Pro-Val
Solubility: H2O
Purity: >99%
Storage: -20°C / 3 years
Half life: Not established
CAS No.: 159492-07-6
*(This is a lyophilised powder and will need reconstitution — We also supply Sterile Water for Reconstitution separately.)
Reconstitution
For peptides supplied as lyophilised powder, reconstitute in bacteriostatic water or sterile saline at the concentration appropriate to your protocol. Allow the vial to come to room temperature before opening, add solvent slowly down the inside wall (do not directly onto the powder), and gently invert until clear. Do not vortex.
Reconstituted solutions are typically stable at 2–8°C for the durations published in the corresponding peer-reviewed reference. For long-term storage, aliquot and freeze at −20°C; avoid repeated freeze–thaw cycles.
Research literature
Selected peer-reviewed publications from PubMed referencing this compound. Provided for research orientation — not an endorsement of any clinical application. Each citation links to the canonical PubMed record.
-
KPV and RAPA Self-Assembled into Carrier-Free Nanodrugs for Vascular Calcification Therapy.
Zhang L et al. · Advanced healthcare materials · 2024
PubMed PMID 39252648 -
A KPV-binding double-network hydrogel restores gut mucosal barrier in an inflamed colon.
Zhao Y et al. · Acta biomaterialia · 2022
PubMed PMID 35245681 -
International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy: A Consensus-Based Approach.
Engelen M et al. · Neurology · 2022
PubMed PMID 36175155
You may also need
Related compounds
